The serum level of NF-κB in COVID-19 patients (n = 41), stratified into non-survivors (n = 23),survivors (n = 18), and subjects that belonged to the control group (n = 20), was measured by RT-PCR. This evidence concerns the gene NFKB1 and COVID-19.